Regis Management Company’s Accretive Health AH Stock Holding History

Regis Management Company’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-125,338	Closed	-$282K	–	91
2016 Q4	$282K	Hold	125,338	–	–	0.05%	72
2016 Q3	$306K	Hold	125,338	–	–	0.05%	67
2016 Q2	$251K	Hold	125,338	–	–	0.05%	62
2016 Q1	$320K	Hold	125,338	–	–	0.07%	57
2015 Q4	$401K	Sell	125,338 -80,000	-39%	-$256K	0.09%	53
2015 Q3	$509K	Sell	205,338 -2,000	-1%	-$4.96K	0.15%	32
2015 Q2	$1.14M	Hold	207,338	–	–	0.29%	30
2015 Q1	$1.2M	Hold	207,338	–	–	0.32%	31
2014 Q4	$1.42M	Sell	207,338 -9,036	-4%	-$62K	0.41%	29
2014 Q3	$1.68M	Hold	216,374	–	–	0.49%	23
2014 Q2	$1.69M	Hold	216,374	–	–	0.48%	24
2014 Q1	$1.73M	Hold	216,374	–	–	0.54%	22
2013 Q4	$1.98M	Hold	216,374	–	–	0.7%	20
2013 Q3	$1.97M	Hold	216,374	–	–	0.64%	21
2013 Q2	$2.34M	Buy	+216,374	New	+$2.28M	0.78%	19

Regis Management Company's AH Position: Q1 2017 in Review

Regis Management Company sold out of Accretive Health (AH) in Q1 2017, closing a stake of 125,338 shares — an estimated $282K sold.

Regis Management Company first reported a position in AH in Q2 2013 and held it in 15 quarters. The position peaked at $2.34M in Q2 2013. 0 funds tracked by Wall St. Rank hold AH as of Q1 2017.

Regis Management Company reported no remaining Accretive Health position as of Q1 2017 after selling out during the quarter.
Regis Management Company sold 125,338 Accretive Health shares in Q1 2017, an estimated $282K.
Regis Management Company first reported a position in Accretive Health in Q2 2013 and held it in 15 quarters.
Regis Management Company's Accretive Health position peaked at $2.34M in Q2 2013.
0 funds tracked by Wall St. Rank held Accretive Health as of Q1 2017.

Based on Regis Management Company's 13F filing for Q1 2017, filed 9 May 2017.